Tatyana Adayev, Ph.D.

2004 City University of New York, New York, NY, United States 
Neuroscience Biology
"Tatyana Adayev"
Mean distance: (not calculated yet)


Sign in to add mentor
Probal Banerjee grad student 2004 CUNY
 (Novel effects of serotonin 1A receptor-mediated signaling through MAP kinase.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dowjat K, Adayev T, Wojda U, et al. (2019) Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Wegiel J, Brown WT, La Fauci G, et al. (2018) The role of reduced expression of fragile X mental retardation protein in neurons and increased expression in astrocytes in idiopathic and syndromic autism (duplications 15q11.2-q13). Autism Research : Official Journal of the International Society For Autism Research
Liu Y, Adayev T, Hwang YW. (2017) An ELISA DYRK1A non-radioactive assay suitable for the characterization of inhibitors. F1000research. 6: 42
Adayev T, LaFauci G, Dobkin C, et al. (2014) Fragile X protein in newborn dried blood spots. Bmc Medical Genetics. 15: 119
LaFauci G, Adayev T, Kascsak R, et al. (2013) Fragile X screening by quantification of FMRP in dried blood spots by a Luminex immunoassay. The Journal of Molecular Diagnostics : Jmd. 15: 508-17
Dowjat K, Adayev T, Kaczmarski W, et al. (2012) Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients. Journal of Neuropathology and Experimental Neurology. 71: 1100-12
Xie W, Adayev T, Zhu H, et al. (2012) Activity-dependent phosphorylation of dynamin 1 at serine 857. Biochemistry. 51: 6786-96
Mazur-Kolecka B, Golabek A, Kida E, et al. (2012) Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice. Journal of Neuroscience Research. 90: 999-1010
Adayev T, Wegiel J, Hwang YW. (2011) Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A). Archives of Biochemistry and Biophysics. 507: 212-8
Wegiel J, Kaczmarski W, Barua M, et al. (2011) Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome. Journal of Neuropathology and Experimental Neurology. 70: 36-50
See more...